 Paul Hudson is CEO of drug giant Sanofi. The more we add AI, the more we improve our decision intelligence, the more opportunity we have to do more in that space. And I think that's what's catching the excitement in our organization. Hudson tells Bloomberg that AI carries potential not only for the drug business, but anyone waiting for treatments and cures.